NCT03946202View on ClinicalTrials.gov

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions
Breast Cancer
Interventions
DRUG

Hydrogen Peroxide

Hydrogen Peroxide

Trial Locations (9)

632004

RECRUITING

Christian Medical Centre, Vellore

695011

RECRUITING

Regional Cancer Centre (RCC), Trivandrum

700160

RECRUITING

Tata Medical Centre, Kolkata

TR1 3LJ

RECRUITING

Royal Cornwall Hospitals NHS Trust, Truro

G12 0YN

RECRUITING

Beatson West of Scotland Cancer Centre, Glasgow

CB2 0QQ

RECRUITING

Cambridge University Hospitals NHS Foundation Trust, Cambridge

M20 4BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

ST4 6QG

RECRUITING

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

SM2 5PT

RECRUITING

The Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors
collaborator

Kortuc, Inc.

INDUSTRY

lead

Institute of Cancer Research, United Kingdom

OTHER